FDA approves genetic test for use with cancer drug
from The Wall Street Journal
The Food and Drug Administration approved a genetic test made by Qiagen N.V. aimed at determining which colon cancer patients would benefit from the cancer drug Erbitux, the company said. Erbitux is approved to treat a certain group of patients with advanced colon cancer as well as head and neck cancer.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063